Long-term histological follow-up of genetically modified myoblasts grafted into the brain

Molecular Brain Research

Volumn 44, Issue 1, 1997, Pages 125-133

  Lisovoski, F ^a   Wahrmann, J P ^b,c   Pages, J C ^b   Cadusseau, J ^a   Rieu, M ^c   Weber, A ^b   Kahn, A ^b   Peschanski, M ^a  

^a INSERM   (France)

^b INSTITUT COCHIN   (France)

^c Lab de Physiologie Respiratoire   (France)

Author keywords

Engineered cell; Gene therapy; Intracerebral transplantation; Muscle cell

Indexed keywords

BETA GALACTOSIDASE; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN GRAFT; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GLIA CELL; GRAFT SURVIVAL; GRAY MATTER; HISTOLOGY; MOLECULAR GENETICS; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; STEREOTAXIC SURGERY; TRANSGENE; WHITE MATTER;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0031015791     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00194-5     Document Type: Article

References (40)

1. Bohn, M.C., Cupit, L., Marciano, F. and Gash, D.M., Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers, Science, 237 (1987) 913-916.
2. Brundin, P., Widner, H., Nilsson, O.G., Strecker, R.B. and Björklund, A., Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier, Exp. Brain Res., 75 (1989) 195-207.
3. Chen, L.S., Ray, J., Fisher, L.J., Kawaja, M.D., Schinstine, M., Kang, U.J. and Gage, F.H., Cellular replacement therapy for neurologic disorders: potential of genetically engineered cells, J. Cell. Biochem., 45 (1991) 252-257.
4. Cunningham, L.A., Hansen, J.T., Short, M.P. and Bohn, M.C., The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum, Brain Res., 561 (1991) 192-202.
5. Dai, Y., Roman, M., Naviaux, R.K. and Verma, I.M., Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo, Proc. Natl. Acad. Sci. USA, 89 (1992) 10892-10895.
6. Danos, O. and Mulligan, R.C., Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges, Proc. Natl. Acad. Sci. USA, 85 (1988) 6460-6464.
7. Decombe, R., Rivot, J.P., Aunis, D., Abrous, N., Peschanski, M. and Herman, J.P., Importance of catecholamine release for the functional action of intrastriatal implants of adrenal medullary cells: pharmacological analysis and in vivo electrochemistry, Exp. Neurol., 107 (1990) 143-153.
8. De La Haba, G. and Bricker, J.V., Formation of striated muscle from myoblasts in vitro. Inhibition of myotube formation by cis-4-hydroxy-L proline and its reversal by native or denatured collagen (gelatin), Mol. Cell. Biochem., 40 (1981) 61-70.
9. Delain, D., Wahrmann, J.P. and Gros, F., Influence of external diffusible factors on myogenesis of cells of the L6 line, Exp. Cell Res., 131 (1981) 217-224.
10. Dhawan, J., Pan, L.C., Tavlath, G.K., Travis, M.A., Lancdot, A.M. and Blau, H.M., Systemic delivery of human growth hormone by injection of genetically engineered myoblasts, Science, 254 (1991) 1509-1512.
11. Doering, L.C. and Chang, P.L., Expression of a novel gene product by transplants of genetically modified primary fibroblasts in the central nervous system, J. Neurosci. Res., 29 (1991) 292-298.
12. Fisher, L.J., Engineered cells: a promising therapeutic approach for neural disease, Restor. Neurol. Neurosci., 8 (1995) 49-57.
13. Fisher, L.J., Jinnah, H.A., Kale, L.C., Higgins, G.A. and Gage, F.H., Primary fibroblasts that produce L-DOPA: long-term survival and behavioral effects when implanted in rats with 6-OHDA lesions, Neuron, 6 (1991) 371-380.
14. Fisher, L.J., Schinstine, M., Salvaterra, P., Dekker, A.J., Thai, L. and Gage, F.H., In vivo production and release of acetylcholine from primary fibroblasts genetically modified to express choline acetyl-transferase, J. Neurochem., 61 (1993) 1323-1332.
15. Frim, D.M., Uhler, T.A., Galpern, W.R., Beal, M.F., Breakfield, X.O. and Isacson, O., Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylperidinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA, 91 (1994) 5104-5108.
16. Gage, F.H. and Fisher, L.J., Intracerebral grafting: a tool for the neurobiologist, Neuron, 6 (1991) 1-12.
17. Gage, F.H., Kawaja, M.D. and Fisher, L.J., Genetically modified cells: applications for intracerebral grafting, Trends Neurosci., 14 (1991) 328-333.
18. Gage, F.H., Wolff, J.A., Rosenberg, M.B., Xu, L., Yee, J.L., Shults, C. and Friedmann, T., Grafting genetically modified cells to the brain: possibilities for the future, Neuroscience, 23 (1987) 795-807.
19. Hansen, J.T., Fiandaca, M.S., Kordower, J.H., Notter, M.F.D. and Gash, D.M., Striatal adrenal medulla/sural nerve cografts in hemiparkinsonian monkeys, Prog. Brain Res., 82 (1990) 573-580.
20. Holtzer, M., Abbot, J. and Lasle, J., Thick and thin filaments in postmitotic mononucleated myoblasts, Anat. Rec., 131 (1958) 567.
21. Jiao, S., Schultz, E. and Wolff, J.A., Intracerebral transplants of primary muscle cells: a potential 'platform' for transgene expression in the brain, Brain Res., 575 (1992) 143-147.
22. Kawaja, M.D., Pagan, A.M., Firestein, B.L. and Gage, F.H., Intracerebral grafting of cultured autologous skin fibroblasts into the rat striatum: an assessment of graft size and ultrastructure, J. Comp. Neurol., 307 (1991) 695-706.
23. Kawaja, M.D. and Gage, F.H., Reactive astrocytes are substrate for the growth of adult CNS axons in the presence of elevated levels of nerve growth factor, Neuron., 7 (1991) 1019-1030.
24. Kawaja, M.D. and Gage, F.H., Morphological and neurochemical features of cultured primary skin fibroblasts of Fischer 344 rats following striatal implantation, J. Comp. Neurol., 317 (1992) 102-116.
25. Kawaja, M.D., Rosenberg, M.B., Yoshida, K. and Gage, F.H., Somatic gene transfer of NGF promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats, J. Neurosci., 12 (1992) 2849-2864.
26. 2+-dependent adhesion molecule, N-cadherin, in myoblast interaction during myogenesis, Exp. Cell Res., 188 (1990) 175-184.
27. Kuhlengel, K.R., Effect of implants prepared from tissue culture of dorsal root ganglions neurons and Schwann cells on growth of corticospinal fibers after spinal cord injury in neonatal rats, Prog. Brain Res., 78 (1988) 199-204.
28. Mesulam, M.M., Tetramethyl benzidine for horseradish peroxidase neurohistochemistry: a non-carcinogenic blue reaction-product with superior sensitivity for visualizing neural afferents and efferents, J. Histochem. Cytochem., 26 (1978) 106-117.
29. Parr, E. and Leiden, J.M., Systemic delivery of recombinant proteins by genetically modified myoblasts, Science, 254 (1991) 1507-1509.
30. Partridge, T.A., Grand, M. and Slopper, J.C., Evidence of fusion between host and donor myoblasts in skeletal muscle grafts, Nature, 275 (1978) 306-308.
31. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
32. Sanes, J.R., Rubinstein, J.L.R. and Nicolas, J.F., Use of recombinant retrovirus to study post-implantation cell lineage in mouse embryos, EMBO J., 5 (1986) 3133-3142.
33. Scharfmann, R., Axelrod, J.H. and Verma, I.I., Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants, Proc. Natl. Acad. Sci. USA, 88 (1991) 4626-4630.
34. Snyder, E.V., Taylor, R.M. and Wolfe, J.H., Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS mouse brain, Nature, 374 (1995) 367-370.
35. Suhr, S.T. and Gage, F.H., Gene therapy for neurologic disease, Arch. Neurol., 50 (1993) 1252-1268.
36. Wahrmann, J.P., Delain, D., Bournoutian, C. and Macleira Coelho, A., Modulation of differentiation in vitro. Influence of the attachment surface on myogenesis, In Vitro, 9 (1981) 752-762.
37. Wakelam, M.J.O., Myoblasts fusion. A mechanistic analysis, Current Topics in Membranes and Transport, 32 (1988) 87-112.
38. Wolff, J.A., Fisher, L.J., Xu, L., Jinnah, H.A., Langlais, P.J., luvone, P.M., O'Malley, K.L., Rosenberg, M.B., Shimohama, S., Friedmann, T. and Gage, F.H., Grafting fibroblasts genetically modified to produce L-DOPA in a rat model of Parkinson disease, Proc. Natl. Acad. Sci. USA, 86 (1989) 9011-9014.
39. Yao, S.N. and Kurachi, K., Expression of human factor IX in mice after injection of genetically modified myoblasts, Proc. Natl. Acad. Sci. USA, 89 (1992) 3357-3361.
40. Yassin, R., Van beers, G.V., Nurse, K.C.E., Al-Anis, S. and Thompson, E.J., A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells, J. Neurol. Sci., 32 (1977) 347-360.